We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Multi-national study reveals lower esophago-gastric cancer risk in menopausal hormone therapy users, suggesting health benefits.
MHT-users seem to have lower odds of developing esophago-gastric cancer.
No takes yet. Share an insight, caveat, or question.
Wocalewski et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: